Middlemen net more than half of insulin expenditures, study finds
Despite its discovery nearly 100 years ago, insulin's list price has been going up, not down, with trade secrets and other protections preventing researchers from pinpointing who is receiving profits from its sale. Meanwhile, ...
Nov 5, 2021
0
9